What is the recommended initial management for adult sepsis, including fluid resuscitation, vasopressor therapy, empiric broad-spectrum antibiotics, and supportive care?

Initial Management of Adult Sepsis

Begin immediate aggressive fluid resuscitation with 30 mL/kg of crystalloids within the first hour, start norepinephrine as the first-line vasopressor to target MAP ≥65 mmHg, and administer broad-spectrum antibiotics within one hour of recognition. 1

Fluid Resuscitation

Crystalloids are the mandatory first-line fluid choice for initial resuscitation and all subsequent volume replacement 1. The Surviving Sepsis Campaign guidelines provide strong recommendations (Grade 1B-1C) for this approach:

• Administer at least 30 mL/kg of crystalloids as an initial fluid bolus in patients with sepsis-induced tissue hypoperfusion and suspected hypovolemia 1
• Some patients will require more rapid administration and greater volumes 1
• Either balanced crystalloids or normal saline can be used, though newer evidence suggests a weak preference for balanced crystalloids 1, 2

Continue fluid administration using a fluid challenge technique as long as hemodynamic parameters continue to improve, assessed by either:

• Dynamic variables (pulse pressure variation, stroke volume variation)
• Static variables (arterial pressure, heart rate) 1

Consider albumin supplementation when patients require substantial amounts of crystalloids (weak recommendation, Grade 2C) 1

Critical pitfall: Absolutely avoid hydroxyethyl starches—there is a strong recommendation against their use (Grade 1B) due to harm 1

Vasopressor Therapy

Norepinephrine is the mandatory first-choice vasopressor (strong recommendation, Grade 1B) 1. The algorithmic approach is:

1. Initial target: MAP ≥65 mmHg (Grade 1C) 1

2. If additional agent needed:

   • Add vasopressin 0.03 units/minute to norepinephrine (to raise MAP or decrease norepinephrine dose) 1
   • OR add/substitute epinephrine (Grade 2B) 1

3. Dopamine is restricted to highly selected patients only (e.g., low tachyarrhythmia risk with bradycardia) 1

4. Phenylephrine is NOT recommended except in three specific salvage scenarios:

   • Norepinephrine causes serious arrhythmias
   • Cardiac output is high but BP persistently low
   • Salvage therapy when other agents fail 1

Important caveat: Low-dose dopamine should never be used for renal protection (Grade 1A) 1

Place an arterial catheter as soon as practical in all patients requiring vasopressors 1

Antimicrobial Therapy

Administer broad-spectrum antibiotics within one hour of sepsis/septic shock recognition 3, 4, 5. This remains a strong recommendation despite being downgraded in certainty when diagnosis is uncertain 2:

• Obtain blood cultures BEFORE antibiotic administration whenever possible 3, 6
• Target the most likely source of infection 4
• Plan for antimicrobial de-escalation once culture data and clinical response are available 4, 5

The 2021 guidelines added nuance for situations where sepsis diagnosis is uncertain, but the one-hour window remains the standard when sepsis or septic shock is recognized 2.

Source Control

Identify or exclude anatomic sources requiring emergent intervention as rapidly as possible, and implement source control as soon as medically and logistically practical 1:

• Use the least physiologically invasive effective intervention (e.g., percutaneous vs. surgical drainage) 1
• Remove intravascular access devices promptly if they are a possible source, after establishing alternative access 1

Additional Supportive Measures

Consider hydrocortisone (200 mg/day) in septic shock refractory to fluid and vasopressor therapy 5, 2. The 2021 guidelines include a new weak recommendation for intravenous corticosteroids when there is ongoing vasopressor requirement 2.

Lactate measurement should be obtained early when sepsis is suspected to guide resuscitation, with lactate clearance as a resuscitation goal 5, 7.

Practical implementation note: The 2021 guidelines now include a weak recommendation for peripheral initiation of vasopressors rather than delaying for central access 2, recognizing that time to intervention affects mortality more than access route.

The evidence base for these recommendations comes primarily from the 2016 Surviving Sepsis Campaign guidelines (published 2017), which represent the most comprehensive and authoritative guidance available, with updates in 2021 that refined rather than fundamentally changed the approach 1, 2.